Peptide Science Basics: Evidence-First Education on Peptides and Health

Bottom line Ipamorelin and CJC-1295 are both growth hormone secretagogues that signal the pituitary gland to release more of the body's own growth hormone, but they work through two distinct receptor pathways. The single human study on CJC-1295, published in 2006, showed sustained GH and IGF-1 increases with no serious adverse reactions, but did not evaluate anti-aging, muscle, or fat-loss outcomes. Multiple 2026 clinical reviews agree there is no good-quality, long-term huma

Key Takeaways BPC-157 and TB-500 are both peptides discussed for soft-tissue recovery, but they come from different biological families and act through different mechanisms. BPC-157 is a synthetic 15-amino-acid fragment derived from a protective protein found in gastric juice, and its research base leans toward gut, tendon, and ligament healing. TB-500 is a synthetic fragment of Thymosin Beta-4, a naturally occurring protein, and its research base leans toward cell migration,

Key Takeaways Semax and Selank are synthetic peptides developed in Russia decades ago and have been used there in approved clinical formulations, but neither is FDA-approved for any indication in the United States. Semax's most-documented mechanism is upregulating brain-derived neurotrophic factor (BDNF), a protein tied to neuron growth, survival, and synaptic plasticity; Selank's most-studied mechanism is modulating the GABA system, the brain's primary calming pathway. The s

Bottom line GHK-Cu is a naturally occurring copper-binding tripeptide with one of the largest bodies of published research among ‘longevity’ peptides, including decades of work on collagen synthesis, wound healing, and antioxidant activity. Topical GHK-Cu (often listed as ‘copper tripeptide-1’ on ingredient labels) is regulated as a cosmetic ingredient in the U.S. and is widely used in commercial serums and creams without requiring FDA pre-approval. Injectable GHK-Cu is a com

Bottom line There is no single yes-or-no answer: a peptide's legality depends on whether it's FDA-approved, its FDA compounding category, and how it's intended to be used. FDA-approved peptides like semaglutide or tirzepatide are legal with a valid prescription, while most peptides driving online interest—BPC-157, TB-500, KPV, MOTS-c—are not FDA-approved and cannot currently be legally compounded for human use. Simple personal possession is not itself a federal crime, but sel

Clinical biohacking is going mainstream in 2026. Here’s what current longevity research actually shows about peptides—and what’s still unproven. Key Takeaways Biohacking is shifting in 2026 from an elite, unregulated subculture toward evidence-based, physician-guided "clinical biohacking"—a convergence of longevity science, functional medicine, and preventive care. Peptides are one of the most discussed tools in this shift, but the evidence base varies enormously by peptide:

Peptides are widely used in recovery science, but the space is a mix of genuine clinical tools and unregulated gray-market products sold under the same name. This piece separates the two, using current 2026 research on both the benefits and the real risks of peptide use in recovery contexts. Key Takeaways Peptides such as growth-hormone-releasing peptides and BPC-157 are widely discussed for muscle repair, inflammation, and recovery, but most supporting evidence remains precl